FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16252011000001102: Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57332801000001111 Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57332901000001117 Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Is a Fenofibrate micronised 160mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Has AMP Supralip 160mg tablets (Lexon (UK) Ltd) true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Has specific active ingredient Fenofibrate micronized true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Lexon (UK) Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start